Overview
Tava Health, based in Salt Lake City, United States, has raised $20M in a Series B round on Mar 1, 2024, with participation from Investor 157. The company headline 96. The round will be used to accelerate product development, expand the team, and scale go-to-market operations.
Operating in the industry 96 sector, Tava Health is positioned to capitalize on growing demand for innovative solutions in this space. The company was founded in 0 by Dallen Allred. Dallen brings deep domain expertise and a track record of execution that attracted investor confidence in this round. With fresh capital, the company is expected to invest heavily in R&D and talent acquisition, signaling a period of aggressive growth ahead.
Market Outlook
The successful raise validates Tava Health's approach and market opportunity. Industry analysts note that companies at this funding stage typically grow headcount by 40-60% within 12 months and make significant technology purchasing decisions in the first quarter post-funding. This makes Tava Health's leadership team particularly valuable contacts for B2B outreach in the near term.
Why contact Tava Health now
Tava Health's $20M Series B raise signals serious investor confidence in their industry 96 play. In the first 90 days post-funding, startups are 3x more likely to respond to outreach and evaluate new partnerships. Their team is hiring, their budget is unlocked, and they need solutions yesterday.
Founders & Contacts
Investors
Company Facts
| Company | Tava Health |
| Amount Raised | $20M |
| Funding Round | Series B |
| Date Raised | Mar 1, 2024 |
| Founded | 0 |
| Industry | Industry 96 |
| Founders | Dallen Allred |
| HQ Location | Salt Lake City, United States |
Get Verified Founder Emails
Access verified email addresses and contact details for Tava Health's founders and thousands of other funded startups.
Start Free Trial